The Journal of Allergy and Clinical Immunology
Volume 123, Issue 6 , Pages 1244-1252.e2, June 2009

IL-22–producing “T22” T cells account for upregulated IL-22 in atopic dermatitis despite reduced IL-17–producing TH17 T cells

  • Kristine E. Nograles, MD

      Affiliations

    • Laboratory for Investigative Dermatology, The Rockefeller University, New York, NY
    • These authors contributed equally to this work.
  • ,
  • Lisa C. Zaba, PhD

      Affiliations

    • Laboratory for Investigative Dermatology, The Rockefeller University, New York, NY
    • These authors contributed equally to this work.
  • ,
  • Avner Shemer, MD

      Affiliations

    • Department of Dermatology, Tel-Hashomer Medical Center, Ramat-Gan, Israel
  • ,
  • Judilyn Fuentes-Duculan, MD

      Affiliations

    • Laboratory for Investigative Dermatology, The Rockefeller University, New York, NY
  • ,
  • Irma Cardinale, MSc

      Affiliations

    • Laboratory for Investigative Dermatology, The Rockefeller University, New York, NY
  • ,
  • Toyoko Kikuchi, MSc

      Affiliations

    • Laboratory for Investigative Dermatology, The Rockefeller University, New York, NY
  • ,
  • Michal Ramon, MD

      Affiliations

    • Department of Dermatology, Rambam Medical Center and the Technion, Haifa, Israel
  • ,
  • Reuven Bergman, MD

      Affiliations

    • Department of Dermatology, Rambam Medical Center and the Technion, Haifa, Israel
  • ,
  • James G. Krueger, MD, PhD

      Affiliations

    • Laboratory for Investigative Dermatology, The Rockefeller University, New York, NY
  • ,
  • Emma Guttman-Yassky, MD, MSc

      Affiliations

    • Laboratory for Investigative Dermatology, The Rockefeller University, New York, NY
    • Department of Dermatology, Weill Cornell Medical College, Cornell University, New York, NY
    • Corresponding Author InformationReprint requests: Emma Guttman-Yassky, MD, MSc, Laboratory for Investigative Dermatology, The Rockefeller University, 1230 York Avenue, New York, NY 10065.

Received 12 December 2008; received in revised form 26 March 2009; accepted 30 March 2009. published online 13 May 2009.

Background

Psoriasis and atopic dermatitis (AD) are common inflammatory skin diseases. An upregulated TH17/IL-23 pathway was demonstrated in psoriasis. Although potential involvement of TH17 T cells in AD was suggested during acute disease, the role of these cells in chronic AD remains unclear.

Objective

To examine differences in IL-23/TH17 signal between these diseases and establish relative frequencies of T-cell subsets in AD.

Methods

Skin biopsies and peripheral blood were collected from patients with chronic AD (n = 12) and psoriasis (n = 13). Relative frequencies of CD4+ and CD8+ T-cell subsets within these 2 compartments were examined by intracellular cytokine staining and flow cytometry.

Results

In peripheral blood, no significant difference was found in percentages of different T-cell subsets between these diseases. In contrast, psoriatic skin had significantly increased frequencies of TH1 and TH17 T cells compared with AD, whereas TH2 T cells were significantly elevated in AD. Distinct IL-22–producing CD4+ and CD8+ T-cell populations were significantly increased in AD skin compared with psoriasis. IL-22+CD8+ T-cell frequency correlated with AD disease severity.

Conclusion

Our data established that T cells could independently express IL-22 even with low expression levels of IL-17. This argues for a functional specialization of T cells such that “T17” and “T22” T-cells may drive different features of epidermal pathology in inflammatory skin diseases, including induction of antimicrobial peptides for “T17” T cells and epidermal hyperplasia for “T22” T-cells. Given the clinical correlation with disease severity, further characterization of “T22” T cells is warranted, and may have future therapeutic implications.

Key words: Atopic dermatitis, psoriasis, TH17, IL-17, IL-22, T22

Abbreviations used: AD, Atopic dermatitis, AMP, Antimicrobial peptide, FACS, Fluorescence-activated cell sorting, SCORAD, Scoring Atopic Dermatitis, Tc, CD8 T cell

 

 Supported by grant #5UL1RR024143-02 from the National Center for Research Resources, a component of the National Institutes of Health, and the National Institutes of Health Roadmap for Medical Research. K.E.N. is supported by the Clinical Scholars Program at the Rockefeller University, and L.C.Z. is supported by National Institutes of Health Medical Scientist Training Program (MSTP) grant GM07739.

 Disclosure of potential conflict of interest: J. G. Krueger receives grant support from Centocor and Wyeth. The rest of the authors have declared that they have no conflict of interest.

PII: S0091-6749(09)00552-1

doi:10.1016/j.jaci.2009.03.041

The Journal of Allergy and Clinical Immunology
Volume 123, Issue 6 , Pages 1244-1252.e2, June 2009